BIOMARIN PHARMACEUTICAL INC Operating Leases, Rent Expense
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Operating Leases, Rent Expense of $12.20 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-02-27
- BIOMARIN PHARMACEUTICAL INC operating leases, rent expense for fiscal 2018 was $12.20M, a 7.02% increase from fiscal 2017.
- BIOMARIN PHARMACEUTICAL INC operating leases, rent expense for fiscal 2017 was $11.40M.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2018-12-31 | $12.20M 10-K · filed 2020-02-27 |
| 2017-12-31 | $11.40M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |